Aspira Women's Health Files Q1 2025 10-Q
Ticker: AWHL · Form: 10-Q · Filed: May 19, 2025 · CIK: 926617
Sentiment: neutral
Topics: 10-Q, financials, diagnostics
TL;DR
Aspira Women's Health filed its Q1 2025 10-Q. Financials and operations update.
AI Summary
Aspira Women's Health Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Vermillion, Inc., is involved in in vitro & in vivo diagnostic substances. Its principal executive offices are located in Austin, Texas.
Why It Matters
This filing provides an update on Aspira Women's Health's financial performance and operational status for the first quarter of 2025, crucial for investors tracking the company's progress in the diagnostics sector.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new information presented.
Key Numbers
- 20250331 — Period End Date (The report covers the financial period ending March 31, 2025.)
- 20250519 — Filing Date (The 10-Q was filed on May 19, 2025.)
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer of the 10-Q
- VERMILLION, INC. (company) — Former name of Aspira Women's Health Inc.
- CIPHERGEN BIOSYSTEMS INC (company) — Former name of Aspira Women's Health Inc.
- ABIOTIC SYSTEMS (company) — Former name of Aspira Women's Health Inc.
- Austin, TX (location) — Location of principal executive offices
FAQ
What is the primary business of Aspira Women's Health Inc.?
Aspira Women's Health Inc. is involved in in vitro & in vivo diagnostic substances, as indicated by its Standard Industrial Classification code.
When was the current 10-Q filing submitted to the SEC?
The 10-Q filing was submitted on May 19, 2025.
What is the fiscal year end for Aspira Women's Health Inc.?
The company's fiscal year ends on December 31.
What were the previous names of Aspira Women's Health Inc.?
Aspira Women's Health Inc. was formerly known as VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC, and ABIOTIC SYSTEMS.
Where are Aspira Women's Health Inc.'s principal executive offices located?
The company's principal executive offices are located at 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 19, 2025 regarding Aspira Women's Health Inc. (AWHL).